Cargando…
Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study
BACKGROUND: Faecal calprotectin (FC) is a potential biomarker for colorectal cancer (CRC) screening. There is uncertainty if tumor characteristics are associated with FC levels. We investigated how tumor stage and tumor localization influence the extent of FC levels in patients with CRC in clinical...
Autores principales: | Blad, Nathalie, Palmqvist, Richard, Karling, Pontus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944005/ https://www.ncbi.nlm.nih.gov/pubmed/35331198 http://dx.doi.org/10.1186/s12885-022-09440-4 |
Ejemplares similares
-
Immunochemical faecal occult blood tests in primary care and the risk of delay in the diagnosis of colorectal cancer
por: Högberg, Cecilia, et al.
Publicado: (2013) -
Guidance on the interpretation of faecal calprotectin levels in children
por: Orfei, Martina, et al.
Publicado: (2021) -
Diagnostic accuracy of faecal calprotectin in patients with active
perianal fistulas
por: Stevens, Toer W, et al.
Publicado: (2019) -
Patient-reported and doctor-reported symptoms when faecal immunochemical tests are requested in primary care in the diagnosis of colorectal cancer and inflammatory bowel disease: a prospective study
por: Högberg, Cecilia, et al.
Publicado: (2020) -
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
por: van Rheenen, Patrick F, et al.
Publicado: (2010)